Demonstrates faster peak analyte concentrations in fast-acting edibles versus standard and placebo, indicating significant differences in absorption rates.
The results indicate that the microencapsulation technology used to create the fast-acting edible enabled analyte concentrations to peak significantly faster compared to the standard and placebo edibles.
No takes yet. Share an insight, caveat, or question.
Conner et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: